Farshad Sheybaee Moghaddam

University of Southern California, USC Norris Comprehensive Cancer Center

Papers

12

Total Citations

77

H-Index

6

About

Farshad Sheybaee Moghaddam is a leading urologic oncologist whose research focuses on robotic surgery for upper tract urothelial carcinoma (UTUC) and testicular cancer. As a key contributor to the ROBUUST 2.0 collaborative group, he has helped advance the field through large-scale, multi-institutional studies. His work on robot-assisted nephroureterectomy (RANU) has been particularly impactful, with his landmark paper analyzing outcomes in over 1,100 patients—the largest series of its kind—garnering 17 citations. He has also investigated kidney-sparing approaches like robotic distal ureterectomy for high-risk distal ureteral tumors, challenging conventional treatment paradigms. Beyond UTUC, Moghaddam has contributed to understanding oncological outcomes following robotic post-chemotherapy retroperitoneal lymph node dissection for testicular cancer. His research has explored critical clinical questions, including the role of neoadjuvant chemotherapy, the impact of bladder cuff excision, and the prognostic value of diagnostic ureteroscopy. With multiple publications in 2024–2025, his work is shaping contemporary urologic oncology practice, providing evidence-based guidance for complex surgical decision-making in high-risk patients.

Research Focus

Key Achievements

6
H-Index
12
Papers
77
Total Citations
6
Avg Citations/Paper
🏆 Most Cited Paper
Robot‐assisted nephroureterectomy: surgical and mid‐term oncological outcomes in over 1100 patients (ROBUUST 2.0 collaborative group)
17 citations · 2024
📈 Most Prolific Year: 2024 (8 Papers)
🤝 Key Collaborators: 122
🏛 Institutions: University of Southern California, USC Norris Comprehensive Cancer Center

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago